Monoclonal TCR-redirected tumor cell killing

Nathaniel Liddy(Immunocore (United Kingdom)), Giovanna Bossi(Immunocore (United Kingdom)), Katherine J. Adams(Immunocore (United Kingdom)), Anna Lissina(Cardiff University), Tara Mahon(Immunocore (United Kingdom)), Namir J. Hassan(Immunocore (United Kingdom)), Jessie Gavarret(Immunocore (United Kingdom)), Frayne Bianchi(Immunocore (United Kingdom)), Nicholas J. Pumphrey(Immunocore (United Kingdom)), Kristin Ladell(Cardiff University), Emma Gostick(Cardiff University), Andrew K. Sewell(Cardiff University), Nikolai M. Lissin(Immunocore (United Kingdom)), Naomi E. Harwood(Immunocore (United Kingdom)), Peter Molloy(Immunocore (United Kingdom)), Yi Li(Immunocore (United Kingdom)), Brian Cameron(Immunocore (United Kingdom)), Malkit Sami(Immunocore (United Kingdom)), Emma Baston(Immunocore (United Kingdom)), Penio Todorov(Immunocore (United Kingdom)), Samantha Paston(Immunocore (United Kingdom)), Rebecca Dennis(Immunocore (United Kingdom)), Jane Harper(Immunocore (United Kingdom)), Steve M. Dunn(Immunocore (United Kingdom)), Rebecca Ashfield(Immunocore (United Kingdom)), A. Johnson(Immunocore (United Kingdom)), Yvonne McGrath(Immunocore (United Kingdom)), Gabriela Plesa(University of Pennsylvania), Carl H. June(University of Pennsylvania), Michael Kalos(University of Pennsylvania), David A. Price(Cardiff University), Annelise Vuidepot(Immunocore (United Kingdom)), Daniel Williams(Immunocore (United Kingdom)), Deborah H. Sutton(Immunocore (United Kingdom)), Bent K. Jakobsen(Immunocore (United Kingdom))
Nature Medicine
May 6, 2012
Cited by 319

Abstract


Related Papers

No related papers found

Powered by citation graph analysis